Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection

/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the results of a clinical...

Related Keywords

Jerusalem ,Israel General ,Israel ,Canada ,Hebrew University ,Yerushalayim ,Canadian ,Chezy Barenholz ,Innocan Pharma ,Iris Bincovich ,Hebrew University Of Jerusalem ,Innocan Pharma Corporation ,Innocan Pharma Ltd ,Yissum Research ,Liposome Research Department ,Development Company Yissum ,Tel Aviv University ,Veterinary Science ,Pharma Ltd ,Development Company ,Professor Chezy Barenholz ,Professor Barenholz ,Innocan Israel ,Otc ,Mallcap ,Cannabis ,Clinical Trials Amp Medical Discoveries ,Animals Amp Pets ,